A Study Evaluating the Efficacy and Safety of Oral Etrasimod in the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease

NCT04173273 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
375
Enrollment
INDUSTRY
Sponsor class

Stopped The study was prematurely discontinued due to a lack of efficacy in sub-study 1

Conditions

Interventions

Sponsor

Pfizer

Collaborators